✦ LIBER ✦

Phase I study of single ascending doses of befloxatone, a new reversible MAO-A inhibitor antidepressant

✍ Scribed by Ansseau, M.; Caillé, P.; Derks, C.; Cieren-Puiseux, I.; Wauthy, J.; Ego, D.; Curet, O.; Thiola, A.; Rovei, V.; Jarreau, F.X.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical profile of befloxatone, a ne

✍ O. Curet; G. Damoiseau-Ovens; C. Sauvage; N. Sontag; P. Avenet; H. Depoortere; D 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 570 KB

Tolerability and antidepressive effect o

✍ Delcker, Andreas; Gaertner, Hans Jörg 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 317 KB

854 RESULTS OF A SAFETY, TOLERABILITY AN

✍ L. Proulx; B. Bourgault; N. Chauret; R. Larouche; M. Tanguay; R. Thibert 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A phase 1 ascending dose study of a subc

✍ J. P. VAVALLE; C. P. RUSCONI; S. ZELENKOFSKE; W. A. WARGIN; J. H. ALEXANDER; R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 430 KB

Overview of the CNS pharmacology of BW 1

✍ Dr. B. R. Cooper; H. L. White; O. Beek; R. M. Norton; G. C. Rigdon; J. L. Howard 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 600 KB

A phase I ascending single-dose study of

✍ Richat Abbas; Bruce A. Hug; Cathie Leister; Myriam El Gaaloul; Stephan Chalon; D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 234 KB